Research ArticleOncology
Combining 18F-FDG PET/CT–Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff, Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Thomas Guiot, Marianne Paesmans, Alain Hendlisz and Patrick Flamen
Journal of Nuclear Medicine October 2019, 60 (10) 1366-1372; DOI: https://doi.org/10.2967/jnumed.118.222919
Erwin Woff
1Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Pashalina Kehagias
2Gastro-Oncology Translational Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Caroline Vandeputte
2Gastro-Oncology Translational Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Lieveke Ameye
3Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium; and
Thomas Guiot
1Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Marianne Paesmans
3Data Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium; and
Alain Hendlisz
4Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Patrick Flamen
1Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 10
October 1, 2019
Combining 18F-FDG PET/CT–Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff, Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Thomas Guiot, Marianne Paesmans, Alain Hendlisz, Patrick Flamen
Journal of Nuclear Medicine Oct 2019, 60 (10) 1366-1372; DOI: 10.2967/jnumed.118.222919
Combining 18F-FDG PET/CT–Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer
Erwin Woff, Pashalina Kehagias, Caroline Vandeputte, Lieveke Ameye, Thomas Guiot, Marianne Paesmans, Alain Hendlisz, Patrick Flamen
Journal of Nuclear Medicine Oct 2019, 60 (10) 1366-1372; DOI: 10.2967/jnumed.118.222919